Summary
Updated Aug 30, 2026
William E. Rote is Chief Research Officer of Travere Therapeutics, Inc. (TVTX). 4 SEC Form 4 filings on record, most recently on 7 May 2026. Most recent open-market trade: sold $121K of TVTX on 7 May 2026. Lifetime open-market sales: $886K.
Recent Transactions
6Every recent SEC Form 4 transaction William E. Rote has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies William E. Rote files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric M. Dube - $15.95M of TVTX open-market activity in the last 12 months
- Elizabeth E. Reed - $4.93M of TVTX open-market activity in the last 12 months
- Sandra Calvin - $3.56M of TVTX open-market activity in the last 12 months
- Roy D. Baynes - $2.55M of TVTX open-market activity in the last 12 months
- Jula Inrig - $1.74M of TVTX open-market activity in the last 12 months
- Christopher R. Cline - $1.46M of TVTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is William E. Rote?
William E. Rote is a corporate insider, tracked as Chief Research Officer of Travere Therapeutics, Inc. (TVTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did William E. Rote last file a Form 4?
The most recent primary Form 4 on record is dated 7 May 2026, one of 4 filings going back to 2026.
Has William E. Rote been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($886K) across all tracked filings.
Where can I see all of William E. Rote's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow William E. Rote and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
